WATER, TRIETHYLHEXANOIN, HYDROGENATED POLY(C6-14 OLEFIN), BUTYLENE GLYCOL, 1,2-HEXANEDIOL, METHYLPROPANEDIOL, NIACINAMIDE, PHENYL TRIMETHICONE, DIETHOXYETHYL SUCCINATE, POLYGLYCERYL-10 MYRISTATE, FRAGRANCE, HIPPOPHAE RHAMNOIDES OIL, ETHYLHEXYLGLYCERIN, ALLANTOIN, HYDROGENATED LECITHIN, HIBISCUS ESCULENTUS FRUIT EXTRACT, CORCHORUS OLITORIUS LEAF EXTRACT, CARUM PETROSELINUM (PARSLEY) EXTRACT, GLUTATHIONE, SODIUM GLUCONATE, ADENOSINE, CELLULOSE GUM, HEXYL CINNAMAL, GLUCONOLACTONE, MELIA AZADIRACHTA LEAF EXTRACT, LINALOOL, MELIA AZADIRACHTA FLOWER EXTRACT, LAVANDULA ANGUSTIFOLIA (LAVENDER) FLOWER WATER, HYACINTHUS ORIENTALIS (HYACINTH) EXTRACT, CENTAUREA CYANUS FLOWER EXTRACT, CHAMOMILLA RECUTITA (MATRICARIA) FLOWER/LEAF EXTRACT, CURCUMA LONGA (TURMERIC) ROOT EXTRACT, BORAGO OFFICINALIS EXTRACT, SALVIA SCLAREA (CLARY) EXTRACT, LIMONENE, ALPHA-ARBUTIN, OCIMUM SANCTUM LEAF EXTRACT, CORALLINA OFFICINALIS EXTRACT, THIOCTIC ACID, BIOTIN, BIOTINOYL TRIPEPTIDE-1, ACETYL HEXAPEPTIDE-8, TRIPEPTIDE-1, TRIPEPTIDE-3, MYRISTOYL PENTAPEPTIDE-17, HEXAPEPTIDE-9
60 capsules per container
The absorption of non-heme iron, from the lumen of the small intestine, requires that the dietary iron, which is predominantly in the oxidized state (Fe 3+ ), be reduced to the ferrous (Fe 2+ ) state
Both RCTs and real-world evidence have demonstrated that SGLT-2 inhibitors slow the progression of NPDR in T2DM patients (135, 155)
